Third clinical trial

The third clinical trial aims to demonstrate the biomarker feasibility to detect concussion in head injured children.

Sample collection of the third clinical trial was conducted by Satasairaala hospital in Pori, Finland. A total of 58 children and adolescents in age 0–17 years were recruited: 28 with suspected mild TBI and 30 healthy controls. 

Sample analysis was recently completed. The results reinforce the biomarker research results and provide evidence for the potential usability in children.